Jane Street’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-301,621
| Closed | -$5.69M | – | 6167 |
|
|
2019
Q3 | $5.69M | Buy |
+301,621
| New | +$3.45M | 0.01% | 903 |
|
|
2018
Q1 | – | Sell |
-16,169
| Closed | -$185K | – | 5734 |
|
|
2017
Q4 | $185K | Buy |
16,169
+1,109
| +7% | +$12.4K | ﹤0.01% | 4242 |
|
|
2017
Q3 | $184K | Buy |
+15,060
| New | +$157K | ﹤0.01% | 4157 |
|
|
2016
Q4 | – | Sell |
-10,124
| Closed | -$332K | – | 4860 |
|
|
2016
Q3 | $332K | Buy |
+10,124
| New | +$308K | ﹤0.01% | 3202 |
|
|
2016
Q2 | – | Sell |
-48,823
| Closed | -$1.2M | – | 4839 |
|
|
2016
Q1 | $1.2M | Buy |
+48,823
| New | +$1.13M | 0.01% | 1690 |
|
|
2015
Q4 | – | Sell |
-6,189
| Closed | -$203K | – | 4672 |
|
|
2015
Q3 | $203K | Sell |
6,189
-10,524
| -63% | -$447K | ﹤0.01% | 3177 |
|
|
2015
Q2 | $885K | Buy |
+16,713
| New | +$608K | 0.01% | 1691 |
|
Jane Street's ALDR Position: Q4 2019 in Review
Jane Street sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 301,621 shares — an estimated $5.69M sold.
Jane Street first reported a position in ALDR in Q2 2015 and held it in 7 quarters. The position peaked at $5.69M in Q3 2019. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.
- Jane Street reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
- Jane Street sold 301,621 Alder Biopharmaceuticals shares in Q4 2019, an estimated $5.69M.
- Jane Street first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 7 quarters.
- Jane Street's Alder Biopharmaceuticals position peaked at $5.69M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.
Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.